CAS 2023788-19-2 | Tirzepatide
Product name: Tirzepatide
CAS number: 2023788-19-2
Molecular formula: C225H348N48O68
Molecular weight: 4813
EINECS Number: 200-001-8
MDL No.：
Tirzepatide (CAS 2023788-19-2)
Dual GIP & GLP-1 Receptor Agonist & Therapeutic Peptide
Product Overview
Tirzepatide, represented by CAS number 2023788-19-2, is a synthetic 39-amino-acid peptide designed as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Incorporating a C20 fatty acid diacid moiety, this compound effectively binds serum albumin to extend half-life and improve physiological metabolic regulation in advanced endocrine research.
Distinctive Features
- Dual Agonist Mechanism: Concurrently targets both GIP and GLP-1 receptors to optimize insulin secretion and lipid metabolism.
- Extended Plasma Half-Life: Fatty acid chain modification promotes albumin binding, allowing sustained bioactivity in experimental models.
- High Peptide Purity: Manufactured via precision solid-phase and liquid-phase peptide coupling to ensure high analytical purity and reproducibility.
- Strict Process Controls: Qualified under rigorous testing standards for endotoxin levels, residual solvents, and peptide content.
Target Applications
Synonyms / Alternative Names
Tirzepatide; Mounjaro; Zepbound; LY3298176; GIP/GLP-1 Tirzepatide; CAS 2023788-19-2.
Hot Tags: cas 2023788-19-2 | tirzepatide, China cas 2023788-19-2 | tirzepatide manufacturers, suppliers, api gdpr compliance for api, api data exchange, api financial management api integration, api expense tracking api integration, api ipsec vpn for api, api chatbot integration
